hyperlipidemia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Aged 18-80 years; 2. TC=5.20mmol/L and TC=6.20mmol/L or LDL-C=3.40mmol/L and =4.10mmol/L; 3. Have the complete four methods of diagnosis information; 4. Informed consent.
Exclusion criteria
Exclusion criteria: if any answer as follow is"yes",the subject can't attend this clinical trial: 1. Familial combined hyperlipidaemia; 2. Ccr<60ml/min; 3. Abnormal liver function, ALT, AST or bilirubin greater than 2 times; 4. Hyperlipidemia caused by specific medicines (eg.diuretic,ß-blocker, glucocorticoid, estrin etc.) Or other diseases; 5. Patients with Heart Failure,cardiac function=NYHA IIIand severe arrhythmia (eg.frequent ventricular premature beat,ventricular tachycardia,atrial fibrillation etc.); 6. Uncontrolled 3 grade hypertension(sitting position diastolic pressure=110mmHg or systolic pressure=180mmHg); 7. FPG=15mmol/L; 8. Using heparin,thyroxine and other drugs that affect blood lipid metabolism,or adopted other lipid-lowering measures in 2 weeks; 9. People with severe or unstable heart,liver,kidney,internal secretion,blood etc. medical problems; 10. Mental?diseaseor alcohol or drug dependence; 11. Malignant tumor patient or have relevant history; 12. Be allergic to statins,or have severe adverse reactions history of statins; 13. people with serious gastrointestinal disease,need to be treated now; 14. Pregnant women, lactating women or plan to pregnant during duration of trial or impregnate; 15. Phatient with serious Hypoxic pulmonary disease,such as asthma,chronic bronchitis,COPD; 16. People unwilling to cooperate; 17. Patients who are with bad compliance, not able to be reviewed regularly; 18. Participated in other clinical trials in the last 3 months; 19. Other unsuitable situation discussed by research group.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| TC;LDL; | — |
Countries
China
Contacts
Guangdong Provincial Hosipital of Chinese Medicine